Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 931 AL 945

Impact of neurologic deficits on motor imagery: a systematic review of clinical evaluations

Di Rienzo F, Collet C, Hoyek N, Guillot A.

Neuropsychol Rev. 2014 Jun;24(2):116-47. doi: 10.1007/s11065-014-9257-6. Epub 2014 Apr 4.

Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review

Malek N, Swallow D, Grosset KA, Anichtchik O, Spillantini M, Grosset DG.

Acta Neurol Scand. 2014 Aug;130(2):59-72. doi: 10.1111/ane.12247. Epub 2014 Apr 5.

The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease

Camilleri A, Vassallo N.

CNS Neurosci Ther. 2014 Jul;20(7):591-602. doi: 10.1111/cns.12264. Epub 2014 Apr 7.

Postprandial hypotension in de novo Parkinson's disease: a comparison with orthostatic hypotension

Umehara T, Toyoda C, Oka H.

Parkinsonism Relat Disord. 2014 Jun;20(6):573-7. doi: 10.1016/j.parkreldis.2014.02.007. Epub 2014 Mar 22.

Dextromethorphan/quinidine for the treatment of pseudobulbar affect

Patatanian E, Casselman J.

Consult Pharm. 2014 Apr;29(4):264-9. doi: 10.4140/TCP.n.2014.264.

Nocturnal manifestations of atypical parkinsonian disorders

Bhidayasiri R, Jitkritsadakul O, Colosimo C.

J Parkinsons Dis. 2014;4(2):223-36. doi: 10.3233/JPD-130280.

Meta analysis of the association of rs7702187 SNP in SEMA5A gene with risk of Parkinson's disease

Yu X, Wang F, Zhang JP.

Eur Rev Med Pharmacol Sci. 2014;18(6):900-4.

Actigraphy as a diagnostic aid for REM sleep behavior disorder in Parkinson's disease

Louter M, Arends JB, Bloem BR, Overeem S.

BMC Neurol. 2014 Apr 6;14:76. doi: 10.1186/1471-2377-14-76.

The effect of funding sources on donepezil randomised controlled trial outcome: a meta-analysis

Killin LO, Russ TC, Starr JM, Abrahams S, Della Sala S.

BMJ Open. 2014 Apr 7;4(4):e004083. doi: 10.1136/bmjopen-2013-004083.

Subacute peripheral neuropathy under duodopa therapy without cobalamin deficiency and despite supplementation

Lehnerer SM, Fietzek UM, Messner M, Ceballos-Baumann AO.

J Neural Transm (Vienna). 2014 Oct;121(10):1269-72. doi: 10.1007/s00702-014-1204-4. Epub 2014 Apr 8.

A dual-tracer study of extrastriatal 6-[18F]fluoro-m-tyrosine and 6-[18F]-fluoro-L-dopa uptake in Parkinson's disease

Li CT, Palotti M, Holden JE, Oh J, Okonkwo O, Christian BT, Bendlin BB, Buyan-Dent L, Harding SJ, Stone CK, DeJesus OT, Nickles RJ, Gallagher CL.

Synapse. 2014 Aug;68(8):325-31. doi: 10.1002/syn.21745. Epub 2014 Apr 22.

Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience

Parashos SA, Luo S, Biglan KM, Bodis-Wollner I, He B, Liang GS, Ross GW, Tilley BC, Shulman LM; NET-PD Investigators.

JAMA Neurol. 2014 Jun;71(6):710-6. doi: 10.1001/jamaneurol.2014.391.

The horses are the first thought but one must not forget the zebras even if they are rare: Stiff person syndrome associated with malignant mesothelioma

Koca I, Ucar M, Kalender ME, Alkan S.

BMJ Case Rep. 2014 Apr 7;2014:bcr2013203455. doi: 10.1136/bcr-2013-203455.

Neurocysticercosis presenting as parkinsonism

Verma R, Anand KS, Sharma BB, Garg J.

Neurol India. 2014 Jan-Feb;62(1):110-1. doi: 10.4103/0028-3886.128362.

[Alpha-synuclein in Parkinson's disease]

Oczkowska A, Kozubski W, Dorszewska J.

Przegl Lek. 2014;71(1):26-32.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias